Is the ketogenic diet effective in specific epilepsy syndromes?

Epilepsy Research

Volumn 100, Issue 3, 2012, Pages 252-257

  Nangia, Srishti ^a   Caraballo, Roberto H ^b   Kang, Hoon Chul ^c   Nordli, Douglas R ^a   Scheffer, Ingrid E ^d  

^a CHILDREN'S MEMORIAL HOSPITAL   (United States)

^b HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

^c Yonsei University College of Medicine   (South Korea)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Dravet syndrome, Epilepsy with myoclonic atonic seizures, Tuberous sclerosis; Epilepsy syndromes; Ketogenic diet; Treatment

Indexed keywords

ANTICONVULSIVE AGENT; CARNITINE; RIBOFLAVIN; THIAMINE; UBIDECARENONE; VIGABATRIN;

ANTICONVULSANT THERAPY; ARTICLE; DIET THERAPY; DISEASE ASSOCIATION; DISEASE CONTROL; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME DEFICIENCY; EPILEPSY; FEBRILE INFECTION RELATED EPILEPSY SYNDROME; HUMAN; INFANTILE SPASM; INTELLECTUAL IMPAIRMENT; KETOGENIC DIET; MENTAL DETERIORATION; MUTATIONAL ANALYSIS; MYOCLONIC ASTATIC EPILEPSY; NEURONAL CEROID LIPOFUSCINOSIS; NEUROPROTECTION; PRIORITY JOURNAL; SEVERE MYOCLONIC EPILEPSY IN INFANCY; TREATMENT DURATION; TREATMENT OUTCOME; TUBEROUS SCLEROSIS;

ANIMALS; EPILEPSY; HUMANS; KETOGENIC DIET; MITOCHONDRIAL DISEASES; SEIZURES; TREATMENT OUTCOME; TUBEROUS SCLEROSIS;

EID: 84864104783     PISSN: 09201211     EISSN: 18726844     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2012.01.015     Document Type: Article

References (38)

1. Berg A.T., Berkovic S.F., Brodie M.J., Buchhalter J., Cross J.H., van Emde Boas W., Engel J., French J., Glauser T.A., Mathern G.W., Moshe S.L., Nordli D., Plouin P., Scheffer I.E. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE commission on classification and terminology, 2005-2009. Epilepsia 2010, 51:676-685.
2. Bough K.J., Rho J.M. Anticonvulsant mechanisms of the ketogenic diet. Epilepsia 2007, 48:43-58.
3. Caraballo R., Cersósimo R., Sakr D., Cresta A., Escobal N., Fejerman N. Ketogenic diet in patients with Dravet syndrome. Epilepsia 2005, 46:1539-1544.
4. Caraballo R.H., Cersosimo R.O., Sakr D., Cresta A., Escobal N., Fejerman N. Ketogenic diet in patients with myoclonic-astatic epilepsy. Epileptic Disord. 2006, 151-155.
5. Caraballo R., Vaccarezza M., Cersosimo R., Rios V., Soraru A., Arroyo H., Agosta G., Escobal N., Demartini M., Maxit C., Cresta A., Marchione D., Carniello M., Panico L. Long-term follow-up of the ketogenic diet for refractory epilepsy: multicenter Argentinean experience in 216 pediatric patients. Seizure 2011, 20:640-645.
6. Caraballo R.H. Non-pharmacological treatments of Dravet syndrome: focus on the ketogenic diet. Epilepsia 2011, 52(Suppl. 2):79-82.
7. Commission on Classification and Terminology of the International League Against Epilepsy Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989, 30:389-399.
8. Connolly M.B., Hendson G., Steinbok P. Tuberous sclerosis complex: a review of the management of epilepsy with emphasis on surgical aspects. Childs Nerv. Syst. 2006, 22:896-908.
9. Coppola G., Klepper J., Ammendola E., Fiorillo M., della Corte R., Capano G., Pascotto A. The effects of the ketogenic diet in refractory partial seizures with reference to tuberous sclerosis. Eur. J. Paediatr. Neurol. 2006, 10:148-151.
10. DeVivo D.C., DiMauro S. Mitochondrial diseases. Pediatric Neurology: Principles & Practice 2006, 715-734. Mosby, St. Louis. 4th ed. K.F. Swaiman (Ed.).
11. DiMauro S., Servidei S., Zeviani M., DiRocco M., DeVivo D.C., DiDonato S., Uziel G., Berry K., Hoganson G., Johnsen S.D., Johnson P.C. Cytochrome c oxidase deficiency in Leigh syndrome. Ann. Neurol. 1987, 22:498-506.
12. Doose H., Gerken H., Leonhardt R., Volzke E., Volz Centrencephalic myoclonic-astatic petit mal. Clinical and genetic investigations. Neuropediatrie 1970, 2:59-78.
13. Dravet Ch., Bureau M., Oguni H., Fukuyama Y., Cokar O. Severe Myoclonic Epilepsy in Infancy (Dravet Syndrome). Epileptic Syndrome in Infancy Chilhood and Adolescence 2002, John Libbey & Co. Ltd., Eastleigh, pp. 81-104. 3rd ed.
14. Engel J. A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology. Epilepsia 2001, 42:796-803.
15. Franz D.N., Tudor C., Leonard J., Egelhoff J.C., Byars A., Valerius K., Sethuraman G. Lamotrigine therapy of epilepsy in tuberous sclerosis. Epilepsia 2001, 42:935-940.
16. Kang H., Kim Y., Kim D., Kim H. Efficacy and safety of the ketogenic diet for intractable childhood epilepsy: Korean multicentric experience. Epilepsia 2005, 46:272-279.
17. Kang H.C., Lee Y.M., Kim H.D., Lee J.S., Slama A. Safe and effective use of the ketogenic diet in children with epilepsy and mitochondrial respiratory chain complex defects. Epilepsia 2007, 48:82-88.
18. Kelley S., Kossoff E. Doose syndrome (myoclonic-astatic epilepsy): 40 years of progress. Dev. Med. Child Neurol. 2010, 52:988-993.
19. Kilaru S., Bergqvist A.G. Current treatment of myoclonic astatic epilepsy: clinical experience at the Children's Hospital of Philadelphia. Epilepsia 2007, 48:1703-1707.
20. Kossoff E.H., Thiele E.A., Pfeifer H.H., McGrogan J.R., Freeman J.M. Tuberous sclerosis complex and the ketogenic diet. Epilepsia 2005, 46:1684-1686.
21. Kunz W.S. The role of mitochondria in epileptogenesis. Curr. Opin. Neurol. 2002, 15:179-184.
22. Laux L.C., Devonshire K.A., Kelley K.R., Goldstein J., Nordli D.R. Efficacy of the ketogenic diet in myoclonic epilepsy of Doose. Epilepsia 2004, 45(Suppl. 7):251.
23. Lombes A., Nakase H., Tritschler H.J., Kadenbach B., Bonilla E., DeVivo D.C., Schon E.A., DiMauro S. Biochemical and molecular analysis of cytochrome c oxidase deficiency in Leigh's syndrome. Neurology 1991, 41:491-498.
24. Martinez C., Pyzik P.L., Kossoff E.H. Discontinuing the ketogenic diet in seizure-free children: recurrence and risk factors. Epilepsia 2007, 48:187-190.
25. Mikaeloff Y., Jambaque I., Hertz-Pannier L., Zamfirescu A., Adamsbaum C., Plouin P., Dulac O., Chiron C. Devastating epileptic encephalopathy in school-aged children (DESC): a pseudoencephalitis. Epilepsy Res. 2006, 69:67-79.
26. Mole, S.E., Williams, R.E. 1993-2001 (updated 2010). In: Pagon, R.A., Bird, T.D., Dolan, C.R., Stephens, K. (Eds.). Neuronal Ceroid-Lipofuscinosis. GeneReviews (Internet). Seattle (WA): University of Washington, Seattle.
27. Mullen S., Marini C., Suls A., Mei D., Della Giustina E., Buti D., Arsov T., Damiano J., Lawrence K., De Jonghe P., Berkovic S.F., Scheffer I.E., Guerrini R. Glucose transporter 1 deficiency as a treatable cause of myoclonic astatic epilepsy. Arch. Neurol. 2011, 10.1001/archneurol.2011.102.
28. Nabbout R., Mazzuca M., Hubert P., Peudennier S., Allaire C., Flurin V., Aberastury M., Sliva W., Dulac O. Efficacy of the ketogenic diet in severe refractory status epilepticus initiating fever induced refractory epileptic encephalopathy in school age children (FIRES). Epilepsia 2010, 51:2033-2037.
29. Nabbout R., Copioli C., Chipaux M. Ketogenic diet also benefits Dravet syndrome patients receiving stiripentol: a prospective pilot study. Epilepsia 2011, 52(7):e54-e57.
30. Neal E.G., Chaffe H., Schwartz R.H., Lawson M.S., Edwards N., Fitzsimmons G., Whitney A., Cross J.H. The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial. Lancet Neurol. 2008, 7:500-506.
31. Nordli D.R., DeVivo D.C. The ketogenic diet. The Treatment of Epilepsy: Principles & Practice 2006, 961-968. Lippincott Williams & Wilkins, New York. 4th ed. E. Wyllie (Ed.).
32. Oguni H., Tanaka T., Hayashi K., Funatsuka M., Sakauchi M., Shirakawa S., Osawa M. Treatment and long-term prognosis of myoclonic-astatic epilepsy of early childhood. Neuropediatrics 2002, 33(3):122-132.
33. Thiele E.A. Managing epilepsy in tuberous sclerosis complex. J. Child Neurol. 2004, 19:680-686.
34. Sakuma H., Awaya Y., Shiomi M., Yamanouchi H., Takahashi Y., Saito Y., Sugai K., Sasaki M. Acute encephalitis with refractory, repetitive partial seizures (AERRPS): a peculiar form of childhood encephalitis. Acta Neurol. Scand. 2010, 121:251-256.
35. Shahwan A., Farrell M., Delanty N. Progressive myoclonic epilepsies: a review of genetic and therapeutic aspects. Lancet Neurol. 2005, 4:239-248.
36. van Baalen A., Hausler M., Boor R., Rohr A., Sperner J., Kurlemann G., Panzer A., Stephani U., Kluger G. Febrile infection-related epilepsy syndrome (FIRES): a nonencephalitic encephalopathy in childhood. Epilepsia 2010, 51:1323-1328.
37. Villeneuve N., Pinton F., Bahi-Buisson N., Dulac O., Chiron C., Nabbout R. The ketogenic diet improves recently worsened focal epilepsy. Dev. Med. Child Neurol. 2009, 51(4):276-281.
38. Williams R.E. The Ketogenic Diet: Use in Late Infantile NCL 2009, Poster June NCL, Hamburg.